Advertisement

Neurogenic Bladder

  • William D. Steers
Chapter
Part of the Springer Specialist Surgery Series book series (SPECIALIST)

Abstract

When an abnormality of the nervous system triggers changes in continence, micturition, or urinary symptoms, the term “neurogenic bladder” is used. The urinary bladder and its outlet are unique among viscera because of their complex interplay of visceral and somatic systems in regulating the lower urinary tract (LUT) and the ability of emotions to affect visceral function. As might be expected, the neural regulation of the lower urinary tract differs from other organ systems in that these structures, although innervated by the autonomic nervous system, are under voluntary control. This duality of autonomic and somatic innervation is suited for switching from involuntary urine storage to voluntary elimination. This chapter provides a brief overview of the organization of the neural pathways and central sites influencing micturition and continence, catalogs those disorders linked to neurogenic bladder and pathology, and briefly outlines how neurogenic bladder disorders can be diagnosed and treated.

Keywords

Stress Urinary Incontinence Lower Urinary Tract Neurogenic Bladder Normal Pressure Hydrocephalus Autonomic Dysreflexia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Lai HH, Boone TB. Urologic management of spinal cord injury. AUA Update Ser. 2008;27:234-243Google Scholar
  2. 2.
    McGuire EJ, Woodside JR, Borden TA. Prognostic value of urodynamic testing in myelodysplasia patients. J Urol. 1983;126:205-210Google Scholar
  3. 3.
    Wein A. Classification of neurogenic voiding dysfunction. J Urol. 1981;125:605-609PubMedGoogle Scholar
  4. 4.
    Steers WD, Gray M. A simple method for teaching about voiding disorders. BJU Int. 2006;97(2):238-242PubMedCrossRefGoogle Scholar
  5. 5.
    Su HC, Polak JM, Mulderry PK, et al. Calcitonin generated peptide immunoreactivity in afferent neurons supplying the urinary tract: combined retrograde tracing and immunohistochemistry. Neuroscience. 1986;18: 727-747PubMedCrossRefGoogle Scholar
  6. 6.
    Vizzard MA, Erdman SL, de Groat WC. Increased expression of neuronal nitric oxide synthase in bladder afferent pathways following chronic bladder irritation. J Comp Neurol. 1996;370:191-202PubMedCrossRefGoogle Scholar
  7. 7.
    Vizzard MA. Up-regulation of pituitary adenylate cyclase-activating polypeptide in urinary bladder pathways after chronic cystitis. J Comp Neurol. 2000;420:335-348PubMedCrossRefGoogle Scholar
  8. 8.
    Chess-Williams R. Muscarinic receptors of the urinary bladder: detrusor, urothelial and pre-junctional. Autonom Autacoid Pharmacol. 2002;22:133-145CrossRefGoogle Scholar
  9. 9.
    Andersson KE, Wein AJ. Pharmacology of the lower urinary tract: basis for current and future treatments of urinary incontinence. Pharmacol Rev. 2004;56(4):581-631PubMedCrossRefGoogle Scholar
  10. 10.
    Schurch B, Hauri D, Rodic B, Curt A, Meyer M, Rossier AB. Botulinum-A toxin as a treatment of detrusor-sphincter dyssynergia: a prospective study in 24 spinal cord injury patients. J Urol. 1996;155(3):1023-1029PubMedCrossRefGoogle Scholar
  11. 11.
    Patel AK, Patterson JM, Chapple CR. Botulinum toxin injections for neurogenic and idiopathic detrusor overactivity: a critical analysis of results. Eur Urol. 2006; 50(4):684-710PubMedCrossRefGoogle Scholar
  12. 12.
    Holstege G, Mouton LJ. Central nervous system control of micturition. Int Rev Neurobiol. 2003;56:123-145PubMedCrossRefGoogle Scholar
  13. 13.
    Nadelhaft PL, Vera JPC, Miselis RR. Central nervous system neurons labelled following the injection of pseudorabies virus into the rat urinary bladder. Neurosci Lett. 1992;143:271-274PubMedCrossRefGoogle Scholar
  14. 14.
    Klausner AP, Streng T, Na YG, et al. The role of corticotropin releasing factor and its antagonist, astressin, on micturition in the rat. Auton Neurosci. 2005;123:26-35PubMedCrossRefGoogle Scholar
  15. 15.
    Link C, Lutfey KE, Steers W, McKinlay JB. Is abuse causally related to urologic symptoms? Results from the Boston Area Community Health (BACH) survey. Eur Urol. 2007;52:397-456PubMedCrossRefGoogle Scholar
  16. 16.
    Tibaek S, Gard G, Klarskov P, Iversen HK, Dehlendorff C, Jensen R. Prevalence of lower urinary tract symptoms (LUTS) in stroke patients: a cross-sectional, clinical survey. Neurourol Urodyn. 2008;27:763-771PubMedCrossRefGoogle Scholar
  17. 17.
    Kolominsky-Rabas PL, Hilz MJ, Neundoerfer B, Heuschmann PU. Impact of urinary incontinence after stroke: results from a prospective population-based stroke register. Neurourol Urodyn. 2003;22:322-327PubMedCrossRefGoogle Scholar
  18. 18.
    Marinkovic S, Badlani G. Voiding and sexual dysfunction after cerebrovascular accidents. J Urol. 2001;165:359-370PubMedCrossRefGoogle Scholar
  19. 19.
    Pavlakis AJ, Siroky MB, Goldstein I, Krane RJ. Neurourologic findings in Parkinson’s disease. J Urol. 1983; 129:80-83PubMedGoogle Scholar
  20. 20.
    Chandiramani VA, Palace J, Fowler CJ. How to recognize patients with Parkinsonism who should not have urological surgery. Br J Urol. 1997;80:100-104PubMedGoogle Scholar
  21. 21.
    Salinas JM, Berger Y, De La Rocha RE, Blaivas JG. Urologic evaluation in the Shy Drager syndrome. J Urol. 1986;135:741-743PubMedGoogle Scholar
  22. 22.
    Sakakibara R, Hattori T, Uchiyama T, Yamanishi T. Videourodynamic and sphincter motor unit potential analyses in Parkinson’s disease and multiple system atrophy. J Neurol Neurosurg Psychiatry. 2001;71: 600-606PubMedCrossRefGoogle Scholar
  23. 23.
    Palace J, Chandiramani VA, Fowler CJ. Value of sphincter electromyography in the diagnosis of multiple system atrophy. Muscle Nerve. 1997;20:1396-1403PubMedCrossRefGoogle Scholar
  24. 24.
    Sakakibara R, Hattori T, Kita K, Arai K, Yamanishi T, Yasuda K. Stress induced urinary incontinence in patients with spinocerebellar degeneration. J Neurol Neurosurg Psychiatry. 1998;64:389-391PubMedCrossRefGoogle Scholar
  25. 25.
    Litwiller SE, Frohman EM, Zimmern PE. Multiple sclerosis and the urologist. J Urol. 1999;161(3):743-757.PubMedCrossRefGoogle Scholar
  26. 26.
    Mori S, Kojima M, Sakai Y, Nakajima K. Bladder dysfunction in dementia patients showing urinary incontinence; evaluation with cystometry. Jpn J Geriartr. 1999; 36:489-494Google Scholar
  27. 27.
    Sakakibara R, Kanda T, Sekido T, et al. Mechanism of bladder dysfunction in idiopathic normal pressure hydrocephalus. Neurourol Urodyn. 2008;27:507-510PubMedCrossRefGoogle Scholar
  28. 28.
    Bech RA, Waldemar G, Gjerris F, Klinken L, Juhler M. Shunting effects in patients with idiopathic normal pressure hydrocephalus: correlation with cerebral and leptomeningeal biopsy findings. Acta Neurochir Wien. 1999;141:633-639PubMedCrossRefGoogle Scholar
  29. 29.
    Lu CJ, Tune LE. Chronic exposure to anticholinergic medications adversely affects the course of Alzheimer disease. Am J Geriatr Psychiatry. 2003;11:458-461PubMedGoogle Scholar
  30. 30.
    McNeal DM, Hawtrey CE, Wolraich ML, Mapel JR. Symptomatic neurogenic bladder in a cerebral palsy population. Dev Med Child Neurol. 1983;25:612-616PubMedCrossRefGoogle Scholar
  31. 31.
    Drigo F, Seren W, Artibani AM, et al. Neurogenic vesico-urethral dysfunction in children with cerebral palsy. Ital J Neurol Sci. 1988;80:151CrossRefGoogle Scholar
  32. 32.
    Leach GE, Farsaii A, Kark P, Raz S. Urodynamic manifestations of cerebellar ataxia. J Urol. 1982;128:348-350PubMedGoogle Scholar
  33. 33.
    Chami N, Miladi HM, Ben S, et al. Continence disorders in hereditary spinocerebellar degeneration: urodynamic findings in 55 cases. Acta Neurol Belg. 1984; 84:194-203PubMedGoogle Scholar
  34. 34.
    Vézina JL, Fox AJ. Double blind study of the toxicity of intrathecal iopamidol and metrizamide in lumbar myelography. J Can Assoc Radiol. 1984;35(3):257-258PubMedGoogle Scholar
  35. 35.
    Gil-Nagel A, Gapany S, Blesi K, Villanueva N, Bergen D. Incontinence during treatment with gabapentin. Neurology. 1997;48:1467-1471PubMedGoogle Scholar
  36. 36.
    Maurice-Williams RS. Micturition symptoms in frontal tumors. J Neurol Neurosurg Psychiatry. 1974; 37:431-436PubMedCrossRefGoogle Scholar
  37. 37.
    Zorn B, Montgomery H, Gray M, Steers W. Urge urinary incontinence and depression. J Urol. 1999; 162:82-84PubMedCrossRefGoogle Scholar
  38. 38.
    Weiss JP, Blaivas JG. Nocturia. J Urol. 2000;163(1):5-12PubMedCrossRefGoogle Scholar
  39. 39.
    Delamarter RB, Bohlman HH, Bodner D, et al. Urologie function after experimental cauda equine. Spine. 1990;15:864-870PubMedCrossRefGoogle Scholar
  40. 40.
    Fanciullacci F, Sandri S, Politi P, Zanollo A. Clinical, urodynamic and neurophysiological findings in patients with neuropathic bladder. Paraplegia. 1989;27:354-358PubMedCrossRefGoogle Scholar
  41. 41.
    Bartolin Z, Vilendecic M, Derezic D. Bladder function after surgery for lumbar intervertebral disk protrusion. J Urol. 1999;161:1885-1887PubMedCrossRefGoogle Scholar
  42. 42.
    Sakakibara R, Hattori T, Yasuda K, Yamanishi T. Micturitional disturbances in acute transverse myelitis. Spinal Cord. 1996;34:481-485PubMedCrossRefGoogle Scholar
  43. 43.
    Berger Y, Blavis JG, Oliver L. Urinary dysfunction in transverse myelitis. J Urol. 1990;144:103-105.PubMedGoogle Scholar
  44. 44.
    Hanus T. Other diseases (transverse myelitis, tropical spastic paraparesis, progressive multifocal leukoencephalopathy, Lyme’s disease). In: Corcos J, Schick E, eds. Textbook of the Neurogenic Bladder. London: Informa; 2003:312-326Google Scholar
  45. 45.
    Broseta E, Osca JM, Morera J, et al. Urological manifestations of herpes zoster. Eur Urol. 1993;24:244-247PubMedGoogle Scholar
  46. 46.
    Anger JT, Saigal CS, Litwin MS. The prevalence of urinary incontinence among community dwelling adult women: results from the National Health and Nutrition Examination Survey. J Urol. 2006;175(2):601-604PubMedCrossRefGoogle Scholar
  47. 47.
    Brown JS, Wessels H, Chancellor MB, et al. Urologic outcomes of diabetes. Diabetes Care. 2005;28(1):177-185PubMedCrossRefGoogle Scholar
  48. 48.
    Kershen RT, Boone TB. Peripheral neuropathies of the lower urinary tract following pelvic surgery and radiation therapy. In: Corcos J, Schick E, eds. Textbook of the Neurogenic Bladder. London: Informa; 2003: 246-255Google Scholar
  49. 49.
    Feifer A, Corcos J. Contemporary role of suprapubic cystotomy in the treatment of neuropathic bladder dysfunction in spinal cord injured patients. Neurourol Urodyn. 2008;27:475-479PubMedCrossRefGoogle Scholar
  50. 50.
    Chancellor MB, Gajewski J, Ackman CFD, et al. Long-term followup of the North American multicenter UroLume trial for the treatment of external detrusor-sphincter dyssynergia. J Urol. 1999;161:1545-1550PubMedCrossRefGoogle Scholar
  51. 51.
    Norton PA, Zinner NR, Yalcin I, Bump RC. Duloxetine versus placebo in the treatment of stress urinary incontinence. Am J Obstet Gynecol. 2002;187:40-48PubMedCrossRefGoogle Scholar

Copyright information

© Springer London 2011

Authors and Affiliations

  • William D. Steers
    • 1
  1. 1.Department of UrologyUniversity of Virginia School of MedicineCharlottesvilleUSA

Personalised recommendations